HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Haozhou Tan Selected Research

SARS-CoV-2 papain-like protease

1/2022Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Haozhou Tan Research Topics

Disease

11COVID-19
03/2024 - 01/2022
3Virus Diseases (Viral Diseases)
12/2023 - 01/2022
2Infections
01/2023 - 01/2023
1acute flaccid myelitis
01/2023
1Paralysis (Palsy)
01/2023
1Mpox (monkeypox)
01/2023
1Smallpox (Variola)
01/2023
1Human Influenza (Influenza)
12/2021

Drug/Important Bio-Agent (IBA)

13Antiviral Agents (Antivirals)IBA
03/2024 - 12/2021
3nirmatrelvirIBA
01/2023 - 08/2022
3nirmatrelvir and ritonavir drug combinationIBA
01/2023 - 08/2022
1UbiquitinIBA
12/2023
1Proteins (Proteins, Gene)FDA Link
12/2023
1brincidofovirIBA
01/2023
1telaprevirIBA
01/2023
1VaccinesIBA
01/2023
1tecovirimatIBA
01/2023
1SARS-CoV-2 3C-like proteinaseIBA
04/2022
1SARS-CoV-2 papain-like proteaseIBA
01/2022
1PolyproteinsIBA
01/2022
1Oseltamivir (Tamiflu)FDA Link
12/2021

Therapy/Procedure

1Therapeutics
01/2023